Cardiome Pharma Corp. at its AGM held on June 22, 2015, approved the appointment of Mark H. Corrigan and Arthur H. Willms as Directors. Dr. Corrigan is currently the Chairman of the Board of Directors at Epirus Biopharmaceuticals Inc. and was a former Board member of Cubist Pharmaceuticals Inc. W. James O'Shea will serve as Cardiome's new Chairman of the Board of Directors, effective immediately.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -5.08% | +3.70% |
2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
1st Jan change | Capi. | |
---|---|---|
+3.70% | 27.65M | |
+7.95% | 72.21B | |
+14.98% | 9.14B | |
-24.60% | 4.33B | |
+15.26% | 4.28B | |
+28.46% | 4.15B | |
+7.76% | 2.19B | |
-35.98% | 1.98B | |
+7.76% | 1.98B | |
-47.71% | 1.68B |
- Stock Market
- Equities
- CORV Stock
- News Correvio Pharma Corp.
- Cardiome Pharma Corp. Announces Executive Appointments